D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
BPMC holding history
Blueprint Medicines Corp in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BPMC overviewAll 13F holders of BPMCFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −388,986−100.0% | Sold out | Holders |
| Q1 2025 | 388,986 | $34.4M | <0.1% | +27,185+7.5% | Added | Holders |
| Q4 2024 | 361,801 | $31.6M | <0.1% | +106,111+41.5% | Added | Holders |
| Q3 2024 | 255,690 | $23.7M | <0.1% | −46,945−15.5% | Reduced | Holders |
| Q2 2024 | 302,635 | $32.6M | <0.1% | −73,542−19.5% | Reduced | Holders |
| Q1 2024 | 376,177 | $35.7M | <0.1% | +26,860+7.7% | Added | Holders |
| Q4 2023 | 349,317 | $32.2M | <0.1% | +335,279+2,388.4% | Added | Holders |
| Q3 2023 | 14,038 | $705.0K | <0.1% | +14,038 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −21,270−100.0% | Sold out | Holders |
| Q1 2023 | 21,270 | $956.9K | <0.1% | −18,086−46.0% | Reduced | Holders |
| Q4 2022 | 39,356 | $1.72M | <0.1% | +7,807+24.7% | Added | Holders |
| Q3 2022 | 31,549 | $2.08M | <0.1% | −6,298−16.6% | Reduced | Holders |
| Q2 2022 | 37,847 | $1.91M | <0.1% | −13,522−26.3% | Reduced | Holders |
| Q1 2022 | 51,369 | $3.28M | <0.1% | −128,398−71.4% | Reduced | Holders |
| Q4 2021 | 179,767 | $19.3M | <0.1% | −27,382−13.2% | Reduced | Holders |
| Q3 2021 | 207,149 | $21.3M | <0.1% | −63,948−23.6% | Reduced | Holders |
| Q2 2021 | 271,097 | $23.8M | <0.1% | +13,355+5.2% | Added | Holders |
| Q1 2021 | 257,742 | $25.1M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.